摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氯-1-甲基-3-(三氟甲基)吡唑-4-羰醛 | 128455-62-9

中文名称
5-氯-1-甲基-3-(三氟甲基)吡唑-4-羰醛
中文别名
5-氯-1-甲基-3-(三氟甲基)吡唑-4-甲醛;3-三氟甲基-1-甲基-1H-5-氯吡唑-4-甲醛
英文名称
5-chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde
英文别名
5-chloro-1-methyl-3-(trifluoromethyl)pyrazole-4-carbaldehyde
5-氯-1-甲基-3-(三氟甲基)吡唑-4-羰醛化学式
CAS
128455-62-9
化学式
C6H4ClF3N2O
mdl
MFCD00068130
分子量
212.559
InChiKey
PZOZNOVIRZSNHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    42-44°C
  • 沸点:
    239.6±40.0 °C(Predicted)
  • 密度:
    1.56±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    34.9
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933199090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H312,H315,H319,H332,H335
  • 储存条件:
    温度:2-8℃,惰性气氛环境下

SDS

SDS:c362118d20e6602ba759a638cb510184
查看
Name: 5-Chloro-1-methyl-3-(trifluoromethyl)-1h-pyrazole-4-carbaldehyde Material Safety Data Sheet
Synonym:
CAS: 128455-62-9
Section 1 - Chemical Product MSDS Name:5-Chloro-1-methyl-3-(trifluoromethyl)-1h-pyrazole-4-carbaldehyde Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
128455-62-9 5-Chloro-1-methyl-3-(trifluoromethyl)- 95+% unlisted
Hazard Symbols: XI
Risk Phrases: 36/37/38

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. May be harmful if absorbed through the skin.
Ingestion:
May cause irritation of the digestive tract. May be harmful if swallowed.
Inhalation:
Causes respiratory tract irritation. May be harmful if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 128455-62-9: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 98 - 101 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C6H4ClF3N2O
Molecular Weight: 213

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents, reducing agents.
Hazardous Decomposition Products:
Hydrogen chloride, chlorine, nitrogen oxides, carbon monoxide, carbon dioxide, fluorine, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 128455-62-9 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Chloro-1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carbaldehyde - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
No information available.
IMO
No information available.
RID/ADR
No information available.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 128455-62-9: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 128455-62-9 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 128455-62-9 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-氯-1-甲基-3-(三氟甲基)吡唑-4-羰醛potassium permanganate 作用下, 以 丙酮 为溶剂, 反应 4.0h, 以70.2%的产率得到5-氯-1-甲基-3-(三氟甲基)吡咯-4-羧酸
    参考文献:
    名称:
    新型含苯并咪唑部分的吡唑羧酰胺和烟酰胺衍生物的设计,合成,抗真菌活性和3D-QSAR研究†
    摘要:
    设计并合成了一系列含有苯并咪唑部分的新型吡唑羧酰胺和烟酰胺衍生物,作为抗真菌候选药物。所有目标化合物均通过FTIR,1 H NMR,13 C NMR,HRMS和元素分析技术进行了表征。化合物T1的结构通过单晶X射线衍射分析进一步确认。在体外评估了目标化合物对四种植物病原真菌(灰葡萄孢,立枯根瘤菌,禾谷镰刀菌和黑斑病菌)的抗真菌活性。)通过菌丝体生长抑制方法。生物测定结果表明,一些化合物对显示出良好的抗真菌活性灰霉病以100μgML -1相比其他三个真菌。为了更好地探索结构-活性关系(SAR),测定并评估了目标化合物对灰葡萄孢的EC 50值。随后,基于被测化合物对灰葡萄孢的抑制活性,使用比较分子场分析(CoMFA)技术进行了3D定量结构-活性关系(3D-QSAR)研究。分子建模结果显示具有交叉验证的q 2的良好预测能力和非交叉验证的r 2值分别为0.578和0.850。
    DOI:
    10.1039/c8nj05150j
  • 作为产物:
    描述:
    2-methyl-5-(trifluoromethyl)-1,2-dihydro-3H-pyrazol-3-one 在 sodium hydroxide三氯氧磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 生成 5-氯-1-甲基-3-(三氟甲基)吡唑-4-羰醛
    参考文献:
    名称:
    US6063734
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • [EN] PYRAZOLE COMPOUNDS AND USE THEREOF IN NOXIOUS ARTHROPOD PESTS CONTROLLING COMPOSITION<br/>[FR] COMPOSES DERIVES DU PYRAZOLE ET LEUR UTILISATION DANS UNE COMPOSITION DE LUTTE CONTRE LES ARTHROPODES NUISIBLES
    申请人:SUMITOMO CHEMICAL CO
    公开号:WO2005075433A1
    公开(公告)日:2005-08-18
    The present invention provides a pyrazole compound of formula (a): ;a noxious arthropod pests controlling composition containing the compound shown by the formula (a) as an active ingredient; and a method for controlling noxious arthropod pests comprising applying an effective amount of the compound shown by the formula (a).
    本发明提供了一种式(a)的吡唑化合物;一种含有所述式(a)化合物作为活性成分的有害节肢动物害虫控制组合物;以及一种控制有害节肢动物害虫的方法,包括施用所述式(a)化合物的有效量。
  • Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents
    作者:Xiaojie Zhang、Rubing Wang、German Ruiz Perez、Guanglin Chen、Qiang Zhang、Shilong Zheng、Guangdi Wang、Qiao-Hong Chen
    DOI:10.1016/j.bmc.2016.08.006
    日期:2016.10
    inhibiting prostate cancer cell proliferation. It can be concluded from our data that 1,9-diarylnona-1,3,6,8-tetraen-5-one can serve as a new potential scaffold for the development of anti-prostate cancer agents and that pyridine-4-yls and quinolin-4-yl act as optimal heteroaromatic rings for the enhanced potency of this scaffold. Two of the most potent compounds, 68 and 75, effectively suppress PC-3 cell
    为了寻求更有效的化学疗法来治疗去势抵抗性前列腺癌并受到姜黄素类似物的启发,二十五个(1 E,3 E,6 E,8 E)-1,9-diarylnona-1,3,6,8通过Wittig反应,然后进行Horner-Wadsworth-Emmons反应,已成功合成了带有两个相同末端杂芳族环的-tetraen-5-ones。其中的二十三种是新化合物。WST-1细胞增殖测定法用于评估其对雄激素敏感性和雄激素敏感性人类前列腺癌细胞系的抗增殖作用。与姜黄素相比,二十五个合成化合物中有十八个具有显着改善的效能。最佳化合物78在抑制前列腺癌细胞增殖方面,β-内啡肽的活性比姜黄素高14到23倍。从我们的数据可以得出结论,1,9-二芳基壬娜-1,3,6,8-四烯基5-one可以作为开发抗前列腺癌药物和吡啶-4-基的新的潜在支架。和喹啉-4-基充当最佳杂芳环,以增强该支架的效能。两种最有效的化合物68和75通过激活细胞凋亡和将细胞周期阻滞在G
  • [EN] INHIBITORS OF HEPATITIS C VIRUS POLYMERASE<br/>[FR] INHIBITEURS DE LA POLYMÉRASE DU VIRUS DE L'HÉPATITE C
    申请人:COCRYSTAL DISCOVERY INC
    公开号:WO2012083105A1
    公开(公告)日:2012-06-21
    The present invention provides, among other things, compounds represented by the general Formula (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R1A, R1B, R2, and R3 are as defined in classes and subclasses herein and compositions (e.g., pharmaceutical compositions) comprising such compounds, which compounds are useful as inhibitors of hepatitis C virus polymerase, and thus are useful, for example, as medicaments for the treatment of HCV infection.
    本发明提供了一种由一般式(I)表示的化合物及其药用盐,其中X、Y、R1A、R1B、R2和R3如本文中的类和子类中所定义,并包括含有这种化合物的组合物(例如,药物组合物),这些化合物可用作丙型肝炎病毒聚合酶的抑制剂,因此可用作治疗HCV感染的药物。
  • [EN] SUBSTITUTED BENZAMIDES AND METHODS OF USE THEREOF<br/>[FR] BENZAMIDES SUBSTITUÉS ET LEURS MÉTHODES D'UTILISATION
    申请人:GENENTECH INC
    公开号:WO2015078374A1
    公开(公告)日:2015-06-04
    The invention provides compounds having the general formula I, and pharmaceutically acceptable salts thereof, wherein the variables RA, RAA, subscript n, ring A, X2, L, subscript m, X1, R1, R2, R3, R4, R5, and RN have the meaning as described herein, and compositions containing such compounds and methods for using such compounds and compositions.
    这项发明提供了具有一般式I的化合物及其药用盐,其中变量RA、RAA、下标n、环A、X2、L、下标m、X1、R1、R2、R3、R4、R5和RN的含义如本文所述,并包含这种化合物的组合物和使用这种化合物和组合物的方法。
  • Stable and reusable nanoscale Fe<sub>2</sub>O<sub>3</sub>-catalyzed aerobic oxidation process for the selective synthesis of nitriles and primary amides
    作者:Kathiravan Murugesan、Thirusangumurugan Senthamarai、Manzar Sohail、Muhammad Sharif、Narayana V. Kalevaru、Rajenahally V. Jagadeesh
    DOI:10.1039/c7gc02627g
    日期:——
    nitriles and amides from easily available starting materials using cost-effective catalysts and green reagents is highly desired. In this regard, herein we report the nanoscale iron oxide-catalyzed environmentally benign synthesis of nitriles and primary amides from aldehydes and aqueous ammonia in the presence of 1 bar O2 or air. Under mild reaction conditions, this iron-catalyzed aerobic oxidation process
    在腈纶或酰胺基团形式的功能化分子中可持续引入氮基是至关重要的,因为在许多生命科学分子,天然产物和材料中都发现了含氮基序。因此,非常需要使用具有成本效益的催化剂和绿色试剂从容易获得的起始原料合成腈和酰胺的方法。就这一点而言,本文报道了在1 bar O 2的存在下,由醛和氨水进行的纳米级氧化铁催化的腈和伯酰胺的环境友好合成。或空气。在温和的反应条件下,该催化的需氧氧化过程继续进行,以合成功能化且结构多样的芳族,脂族和杂环腈。另外,应用该基方案,还已经在介质中制备了伯酰胺。
查看更多